Skip Navigation

COVID-19 Update

We continue to monitor COVID-19 cases in our area and providers will notify you if there are scheduling changes. Please continue to call your providers with health concerns. We are providing in-person care and telemedicine appointments.

Learn about our expanded patient care options and visitor guidelines.

General Information | Self-Checker | Donate and Lend Support | Staff Appreciation | Get Email Alerts

Find a Doctor

Find a Researcher


Julie Jisun Paik, M.D., M.H.S.

Photo of Dr. Julie Jisun Paik, M.D., M.H.S.
  • Assistant Professor of Medicine

Specializes in: Adults (18+ years)


Languages: English, Korean


Myositis, Rheumatology, Scleroderma

Research Interests

Myositis, scleroderma, scleroderma associated myopathy

Request an Appointment

Insurance Information



Outside of Maryland

Request Appointment

International Patients

Request Appointment


Johns Hopkins Bayview Medical Center

Appointment Phone: 443-997-1552
301 Mason Lord Drive
Myositis Center
Baltimore, MD 21224 map
Phone: 410-550-6962

Johns Hopkins Bayview Medical Center

5501 Hopkins Bayview Circle
Asthma and Allergy Center 1B.1
Baltimore, MD 21224 map
Phone: 410-550-7715


Dr. Paik completed her Rheumatology fellowship at Johns Hopkins. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma, specifically focusing on the neuromuscular manifestations of scleroderma.

This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. more


  • Assistant Professor of Medicine

Departments / Divisions

Centers & Institutes



  • MD, The George Washington University School of Medicine (2006)


  • Cedars-Sinai Medical Center / Internal Medicine (2010)


  • Johns Hopkins University School of Medicine / Rheumatology (2013)

Additional Training

  • Diplomate, American Board of Internal Medicine
  • Diplomate, American Board of Internal Medicine - Rheumatology

Research & Publications

Research Summary

Muscle disease in scleroderma is common and is associated with poor outcomes such as disability and sudden cardiac death. We have developed a sub-cohort of weak scleroderma patients and are beginning to study the mechanisms driving muscle disease and also interventions to halt or improve strength in this special group of patients. 

Clinical Trials

Dr. Paik is a co-investigator involved in clinical trials focused in Refractory Dermatomyositis

Selected Publications

Paik JJ, Wigley FM, Lloyd TE, Corse AM, Casciola-Rosen L, Shah AA, Boin F, Hummers LK, Mammen AL. The spectrum of muscle histopathologic findings in 42 weak scleroderma patients. Arthritis Care Res (Hoboken). 2015 May 18. Doi:10.1002/acr.22620

Paik JJ, Mammen AL, Wigley FM, Gelber AC. Myopathy in scleroderma, its identification, prevalence, and treatment: lessons learned from cohort studies. Curr Opin Rheumatol. 2014 Mar;26(2):124-30

Paik JJ, Corse AM, Mammen AL. The co-existence of myasthenia gravis in patients with myositis: a case series. Semin Arthritis Rheum 2014 Jun;43(6):792-6

Chung T, Christopher-Stine L, Paik JJ, Corse A, Mammen AL. The composition of cellular infiltrates in anti-HMG-CoA reductase-associated myopathy. Muscle Nerve. 2015 Aug;52(2); 189-95

Academic Affiliations & Courses

Graduate Program Affiliation

GTPCI (Graduate Training Program of Clinical Investigation)

Activities & Honors


  • Clinical to Research Transition Award, Arthritis Foundation, 2013


  • American College of Rheumatology
  • International Myositis Assessment and Clinical Research

Professional Activities

  • Member, Diversity Council

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 


Is this you? Edit Profile
back to top button